Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenue, net of returns, allowances and discounts $ 19,565 $ 16,294
Cost of revenues 6,763 6,051
Gross profit 12,802 10,243
Operating expenses    
Selling, general and administrative 28,090 35,325
Royalties 820 1,093
Research and product development 121 859
Milestone expense to licensor 0 1,000
Acquisition-related (365) 2,959
Change in fair value of contingent consideration liability 35 (10,065)
Impairment charges 10,300 10,895
Total operating expenses 39,001 42,066
Loss from operations (26,199) (31,823)
Other (expense) income    
Interest expense (2,282) (2,541)
Change in fair value of warrant liability 692 841
Warrant modification expense (803) 0
Loss on early extinguishment of debt, net (214) (373)
Other income 206 142
Total other expense (2,401) (1,931)
Loss from continuing operations before tax (28,600) (33,754)
Income tax benefit 743 715
Loss from continuing operations (27,857) (33,039)
Discontinued operations:    
Income from discontinued operations, net of tax of $0 for the years ended December 31, 2017 and 2016 454 1,485
Gain on sale of assets, net of tax of $0 for the years ended December 31, 2017 and 2016 1,696 3,311
Income from discontinued operations, net of tax 2,150 4,796
Net loss $ (25,707) $ (28,243)
Net loss per basic and diluted common share:    
Loss from continuing operations $ (6.49) $ (11.81)
Income from discontinued operations 0.11 0.53
Gain on sale of assets 0.4 1.18
Total from discontinued operations 0.51 1.71
Income from discontinued operations    
Net loss per basic and diluted common share $ (5.98) $ (10.10)
Weighted average shares used in computing net loss per basic and diluted common share 4,291,600 2,796,563